What BNH Investment does

BNH Investment is a Seoul, South Korea-based private investment company founded in 2015, operating as a venture capital investor focused on the bio and healthcare sectors. The firm deploys capital into Korean life sciences and deep-technology startups, and its disclosed portfolio activity is concentrated in two March 2026 transactions: participation as a new investor in MustBio's KRW 35 billion Series C (pre-money valuation KRW 94 billion), a 2021-founded biotech developing next-generation immune anticancer drug pipelines MB5 and MB7, alongside Korea Investment Partners, Atinum Investment, and other institutional investors; and a follow-on investment in LABINCUBE's KRW 14.7 billion (approximately $9.9M USD) Series B, alongside MetaBiomed as a strategic investor, Union Investment Partners, and JKP Partners. LABINCUBE is a Sookmyung Women's University faculty startup recognized as the world's first company to commercialize Metal-Organic Framework (MOF) materials and selected as a baby unicorn by the Ministry of SMEs and Startups.

The firm's business model is that of a sector-specialized venture capital investor: it raises capital from undisclosed limited partners, deploys that capital into Korean bio and healthcare startups across funding stages (Series B through Series C), and seeks returns through eventual exits; revenue mechanics therefore consist of management fees on committed capital plus carried interest on realized gains, though neither fee schedule, fund size, AUM, portfolio count beyond the two disclosed, nor exit track record are publicly available. Its go-to-market appears relationship-driven within the Korean VC and institutional investor ecosystem (co-investing with established names such as Korea Investment Partners, Atinum Investment, Union Investment Partners, and JKP Partners), and its customer base (LPs) is not disclosed. The company's own website at bnhinv.com is not currently accessible to the public, displaying only an automated security verification page, and the firm maintains no publicly disclosed headcount, leadership team, or office footprint information in the source material.

Name

BNH Investment

Website

https://bnhinv.com

Company type

Private

Founded year

2015

Operating status

Operating

Short description

BNH Investment is a Seoul-based private venture capital firm founded in 2015, specializing in bio and healthcare investments. It deploys capital into Korean life sciences startups, including recent investments in MustBio (immuno-oncology) and LABINCUBE (advanced materials).

Ownership category

akta.pro rank

Product category

Venture Capital / Bio-Healthcare Investment

NAICS

All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industry

Business Services (B2B) Growth Equity (FSANACAD)

Keywords

• Venture capital investing
• Biotech investment
• Healthcare venture funding
• Life sciences investment
• Growth-stage bio funding

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales

Core offering

BNH Investment is a venture capital firm that invests in bio and healthcare sector companies. It provides growth-stage equity funding, participating as an existing or new investor in Series B and Series C funding rounds for South Korean biotech and life sciences startups, including companies commercializing MOF-based advanced materials and immune anticancer drug pipelines.

Differentiator

Problem solved

Functional benefit

Products and services

• Growth-stage equity investment in bio and healthcare startups Equity capital participation in Series B and Series C funding rounds for South Korean biotech, life sciences, and advanced materials startups. Targets the bio and healthcare sector and is offered to portfolio companies seeking growth-stage financing.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves2 records

Expansion highlights3 records

Direct peers

• Solidus Investment: Korean venture capital firm active in biotech, healthcare, and deep-tech investments. Comparable as a Korea-based growth investor with similar sector focus and stage participation to BNH.
• IMM Investment: Korean alternative investment manager with venture and growth equity exposure across healthcare and technology. Comparable as a domestic institutional investor writing growth-stage checks in Korea.
• DSC Investment: Korean venture capital and growth equity firm focused on technology and life sciences sectors. Directly comparable as a Korean growth-stage investor participating in similar Korean biotech and tech rounds.
• Atinum Investment: Korean venture and growth equity investor with active biotech and healthcare portfolio. Co-invested alongside BNH in MustBio's Series C, making it a directly comparable growth-stage Korean healthcare investor.
• Korea Investment Partners: One of Korea's largest venture capital and growth equity firms with deep bio/healthcare investing capability. Directly comparable as it co-invested with BNH Investment in MustBio's Series C and targets similar Korean growth-stage companies.
• InterVest: Korea-based venture capital and growth equity firm investing across technology and life sciences. Directly comparable as a Korean growth investor operating at similar stages and check sizes to BNH.
• Smilegate Investment: Korean venture capital firm with diversified portfolio spanning deep-tech and biotech. Comparable as a Korean growth-stage investor with similar participation dynamics in syndicated rounds.
• Mirae Asset Venture Investment: Major Korean venture capital arm of Mirae Asset with broad portfolio including biotech and deep-tech. Comparable to BNH as a Korean growth investor participating in similar rounds and stages.

Broad incumbents

• NH Investment & Securities: Major Korean financial institution with venture and alternative investment operations. Comparable as a broader financial services player with venture capital capabilities in Korea.
• Hyundai Investment Partners: Investment arm of Hyundai with broader industrial portfolio including venture and growth equity. Comparable as a large Korean institutional investor, though typically writing larger checks than BNH.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments43 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BNH Investment